Based on the publicly available clinical datasets, we found that EPHA10 mRNA expression varied among different cancer types (Fig. 1A), indicating that the effect of EPHA10 was tissue-specific and likely dependent on the milieu of binding partners and related target gene regulation in a given cell type. This evidence concerns the gene EPHA10 and cancer.